Squamous Cell Non Small Cell Lung Cancer
Oncology·MeSH: Colorectal Neoplasms
Prevalence
6.0 / 100K
Incidence
8.0 / 100K/yr
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Lorigerlimab | MACROGENICS INC (MGNX) |
Frequently asked questions
How many drugs are in development for Squamous Cell Non Small Cell Lung Cancer?
BioSniper tracks 1 drug in development for Squamous Cell Non Small Cell Lung Cancer across 1 company.
How many clinical trials target Squamous Cell Non Small Cell Lung Cancer?
There are 2 clinical trials targeting Squamous Cell Non Small Cell Lung Cancer tracked by BioSniper.
What is the prevalence of Squamous Cell Non Small Cell Lung Cancer?
The estimated prevalence of Squamous Cell Non Small Cell Lung Cancer is approximately 6.0 per 100,000 population.
Deep-dive into Squamous Cell Non Small Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis